Paladin Advisory Group, LLC Organon & Co. Call Options Transaction History

Paladin Advisory Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Jan 11, 2023	SELL	$23.31 - $28.61 $512 - $629	-22 Reduced 1.59%	1,364 $0
Q3 2022 Oct 07, 2022	BUY	$23.4 - $34.25 $140 - $205	6 Added 0.43%	1,386 $32,000
Q2 2022 Jul 06, 2022	BUY	$31.66 - $38.9 $1,234 - $1,517	39 Added 2.91%	1,380 $46,000
Q4 2021 Jan 11, 2022	BUY	$28.67 - $37.13 $38,446 - $49,791	1,341 New	1,341 $40,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Paladin Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Paladin Advisory Group, LLC with notifications on news.